Adding a short course of androgen deprivation to SBRT cut risk of disease progression in half.
What’s New
- Triplet Regimens in Metastatic Hormone-Sensitive Prostate Cancer
- Advanced Prostate Cancer
- IMPLEMENT Study Reveals Barriers to Treatment Intensification in Metastatic Prostate Cancer
- Study of Oligorecurrent Prostate Cancer Finds Winning Combination
- Talzenna Plus Xtandi May Improve Survival in Metastatic Castration-Resistant Prostate Cancer